A retrospective study of EGF and ofloxacin drops in the healing of human large traumatic eardrum perforation




Abstract


Objective


We evaluated the effects of epidermal growth factor (EGF) and ofloxacin otic drops on the healing of large human traumatic tympanic membrane perforations (TMPs).


Study design


Case series with chart review.


Setting


Tertiary university hospital.


Methods


Retrospective case review of patients with traumatic TMP larger than 25% of the TM seen between February 2007 and December 2008. Patients were stratified into EGF drops, ofloxacin drops, and observation groups. The closure rate, closure time, and hearing level were compared among the three groups at 6 months.


Results


In total, 120 patients met the inclusion criteria. The total closure rate was 89.2% (107/120) and the total mean closure time was 22.6 ± 7.4 days. The closure rates of perforation in the EGF, ofloxacin otic drops, and observation groups were 93.5%, 92.0%, and 82.2%, respectively. The closure rates among the three groups were not statistically different ( p = 0.19). The mean perforation closure times were 12.6 ± 6.9, 12.9 ± 5.1, and 35.7 ± 9.2 days for the EGF, ofloxacin otic drops, and observation groups, respectively. The average closure time in the observation group was significantly longer ( p = 0.01) than that in the EGF and ofloxacin otic drops groups. However, the closure times in the EGF and ofloxacin otic drops groups were not significantly different ( p = 0.84).


Conclusions


The study surprisingly found that both topical application of EGF and ofloxacin otic drops result in more rapid closure compared with spontaneous healing for human large traumatic TMPs. The benefit would be great as a shorter recovery time may reduce health care costs. Therefore, ofloxacin otic drops should be considered in clinics.



Introduction


Traumatic tympanic membrane perforation (TMP) is often seen in the otology clinic, and it can result in conductive hearing loss, tinnitus, and middle ear infection . Most traumatic TMPs heal spontaneously ; however, larger perforations are difficult to repair, the reported spontaneous closure rate for large perforations is 38–78.9% and the mean closure time is 8–12 weeks . Controversy persists regarding the treatment of large TMPs. Most otolaryngologists prefer treatment by observation while keeping the ear dry , but others have suggested that early interventions improve the closure rate and shorten the closure time .


Recently, polypeptide growth factors have frequently been used to repair experimental and clinical TMPs with satisfactory effects . Santa et al. found that epidermal growth factor (EGF) played an important role in the healing of wounds in the TM, including a role in keratinocyte proliferation and migration. Topical application of exogenous EGF accelerated the closure of acute TMPs in rats and chronic TMPs in chinchillas ; however, similar effects have not been observed in the clinic for chronic TMP .


This study retrospectively investigated the effects and short-term complications of topical application of EGF and ofloxacin otic drops in human large traumatic TMPs compared with conservative treatment.





Materials and methods


This retrospective study was approved by institutional review board of Affiliated YiWu Hospital of Wenzhou Medical University. The patient records/information was anonymized and de-identified prior to analysis. The clinical records of traumatic TMP patients who presented to the Otolaryngology Outpatient Clinic in Wenzhou Medical College-Affiliated Yiwu Hospital from February 1, 2007 to December 31, 2008 were retrospectively reviewed. Cases that met the following inclusion criteria were retrieved for analysis: (1) traumatic TMPs resulting from blunt injuries, such as physical blows (e.g., open-hand slap, fist strikes, or ball hits); (2) a perforation size of at least one quarter of the pars tensa and no middle ear infection or vertigo at the initial visit; (3) no ossicular chain damage, confirmed by computed tomography (CT) of the temporal bone and an endoscopic examination; (4) EGF treatment, ofloxacin drops treatment, or only observation was adopted; and (5) otoendoscopy video images of the healing process were recorded twice weekly until closure of the perforation or the 6-month follow-up assessment. Any patient with pre-existing ear disease or perforation resulting from explosive blasts, direct penetration injury, or chemical injury was excluded. A ‘large’ perforation was defined as one exceeding 25% of the entire TM when viewed using ImageJ software (NIH, Bethesda, MD) .


All of the recorded otoendoscopic video images were imported into a computer for storage. The clinical records were studied to obtain demographic data, cause of injury, duration of injury, size of perforation, secondary purulent otorrhea status, method of repair, closure time, and pretreatment and postclosure hearing levels. Data were subsequently analyzed to determine the outcomes of the techniques used. Pure-tone averages were determined for air and bone conductions at 500, 1000, 2000, and 4000 Hz. Treatment methods and their advantages and disadvantages were carefully described by the clinician when the patients visited the first time. Following these descriptions, patients were divided into three groups based on the patient’s self-selection: observation group, EGF-treated group, and ofloxacin otic drops.



Technical methods



Observation group


Patients in this group received no intervention, but underwent regular follow-up.



EGF-treated group


Approximately 0.1–0.15 mL (2–3 drops) of recombinant human epidermal growth factor eye drops (rhEGF; 200 μg/20 g) (Hua Nuo; Guilin, China) was applied to the TM once a day; the edge of the perforation was not approximated, and no scaffolding material was used.



Ofloxacin otic drops group


Approximately 0.1–0.15 mL (2–3 drops) of 0.5% ofloxacin otic drops (Wanhe; Shenzhen, China) was applied to the TM once a day, the edge of the perforation was not approximated, and no scaffolding material was used.


The patients themselves applied the EGF drops or ofloxacin otic drops once a day until closure of the perforation was confirmed by a physician. The eardrops were applied before bed; the patient keeps a lateral position with the injured ear upwards for 30 min after instilling 2–3 drops eardrops in the external auditory canal so that the eardrops contacted the residual TM. The dose of eardrops kept the residual TM moist (not excessively wet or dry). The patients were followed-up 2 or 3 days after treatment commencement so that the physician could determine whether the dose of eardrops was correct and whether purulent otorrhea developed. Incorrect application could be corrected in a timely manner. The patient was advised to discontinue the ear drops if the ear symptoms disappeared or purulent otorrhea occurred. Oral amoxicillin was administered if purulent otorrhea occurred. In addition, all patients were followed regularly, at least once per week, until the perforation was completely closed, or for up to 6 months following treatment.


Results are given as the mean ± standard deviation or as a percentage. For statistical analysis of the results of the three groups, one-way analysis of variance or Kruskal–Wallis testing was performed for continuous data, and the χ 2 test was used for categorical data. A two-sample t -test or the Mann–Whitney U -test was used to compare the results of two groups. A p -value of < 0.05 was considered to indicate statistical significance. Statistical analyses were carried out using SPSS (ver. 11.0 for Windows; SPSS).





Materials and methods


This retrospective study was approved by institutional review board of Affiliated YiWu Hospital of Wenzhou Medical University. The patient records/information was anonymized and de-identified prior to analysis. The clinical records of traumatic TMP patients who presented to the Otolaryngology Outpatient Clinic in Wenzhou Medical College-Affiliated Yiwu Hospital from February 1, 2007 to December 31, 2008 were retrospectively reviewed. Cases that met the following inclusion criteria were retrieved for analysis: (1) traumatic TMPs resulting from blunt injuries, such as physical blows (e.g., open-hand slap, fist strikes, or ball hits); (2) a perforation size of at least one quarter of the pars tensa and no middle ear infection or vertigo at the initial visit; (3) no ossicular chain damage, confirmed by computed tomography (CT) of the temporal bone and an endoscopic examination; (4) EGF treatment, ofloxacin drops treatment, or only observation was adopted; and (5) otoendoscopy video images of the healing process were recorded twice weekly until closure of the perforation or the 6-month follow-up assessment. Any patient with pre-existing ear disease or perforation resulting from explosive blasts, direct penetration injury, or chemical injury was excluded. A ‘large’ perforation was defined as one exceeding 25% of the entire TM when viewed using ImageJ software (NIH, Bethesda, MD) .


All of the recorded otoendoscopic video images were imported into a computer for storage. The clinical records were studied to obtain demographic data, cause of injury, duration of injury, size of perforation, secondary purulent otorrhea status, method of repair, closure time, and pretreatment and postclosure hearing levels. Data were subsequently analyzed to determine the outcomes of the techniques used. Pure-tone averages were determined for air and bone conductions at 500, 1000, 2000, and 4000 Hz. Treatment methods and their advantages and disadvantages were carefully described by the clinician when the patients visited the first time. Following these descriptions, patients were divided into three groups based on the patient’s self-selection: observation group, EGF-treated group, and ofloxacin otic drops.



Technical methods



Observation group


Patients in this group received no intervention, but underwent regular follow-up.



EGF-treated group


Approximately 0.1–0.15 mL (2–3 drops) of recombinant human epidermal growth factor eye drops (rhEGF; 200 μg/20 g) (Hua Nuo; Guilin, China) was applied to the TM once a day; the edge of the perforation was not approximated, and no scaffolding material was used.



Ofloxacin otic drops group


Approximately 0.1–0.15 mL (2–3 drops) of 0.5% ofloxacin otic drops (Wanhe; Shenzhen, China) was applied to the TM once a day, the edge of the perforation was not approximated, and no scaffolding material was used.


The patients themselves applied the EGF drops or ofloxacin otic drops once a day until closure of the perforation was confirmed by a physician. The eardrops were applied before bed; the patient keeps a lateral position with the injured ear upwards for 30 min after instilling 2–3 drops eardrops in the external auditory canal so that the eardrops contacted the residual TM. The dose of eardrops kept the residual TM moist (not excessively wet or dry). The patients were followed-up 2 or 3 days after treatment commencement so that the physician could determine whether the dose of eardrops was correct and whether purulent otorrhea developed. Incorrect application could be corrected in a timely manner. The patient was advised to discontinue the ear drops if the ear symptoms disappeared or purulent otorrhea occurred. Oral amoxicillin was administered if purulent otorrhea occurred. In addition, all patients were followed regularly, at least once per week, until the perforation was completely closed, or for up to 6 months following treatment.


Results are given as the mean ± standard deviation or as a percentage. For statistical analysis of the results of the three groups, one-way analysis of variance or Kruskal–Wallis testing was performed for continuous data, and the χ 2 test was used for categorical data. A two-sample t -test or the Mann–Whitney U -test was used to compare the results of two groups. A p -value of < 0.05 was considered to indicate statistical significance. Statistical analyses were carried out using SPSS (ver. 11.0 for Windows; SPSS).

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Aug 23, 2017 | Posted by in OTOLARYNGOLOGY | Comments Off on A retrospective study of EGF and ofloxacin drops in the healing of human large traumatic eardrum perforation

Full access? Get Clinical Tree

Get Clinical Tree app for offline access